EPINEPHrine IV bags recalled nationwide due to lack of sterility assurance
Central Admixture Pharmacy Services is recalling 9,121 epinephrine IV bags distributed nationwide due to lack of sterility assurance and insufficient validation data for decontamination cycles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an injectable product with unvalidated decontamination processes. No illnesses or hospitalizations reported in the source material, so per rubric criteria this rates as High (score 3) rather than Severe, as the hazard remains theoretical rather than realized.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 9,121 bags of EPINEPHrine 4mg/250mL added to 0.9% sodium chloride IV bags distributed nationwide. The recall was initiated because the manufacturer lacks assurance of sterility and has not provided adequate validation data for decontamination cycles used in the compounding process.
These are prescription-only injectable medications supplied to hospitals and other healthcare facilities. The affected lots have expiration dates ranging from July 2023 through September 2023.
Healthcare facilities that received any of the affected lots should immediately discontinue use and quarantine the product for return to the manufacturer or their pharmaceutical supplier. Verify inventory against the affected lot numbers and expiration dates provided in the recall notice.
The recalled product
- Product
- EPINEPHrine 4mg/250mL added to 0.9% sodium chloride, IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-8093-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable / Compounded
- Affected units
- 9,121
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 36-239250
- Exp. 7/10/2023
- 36-240225
- Exp.7/16/2023
- 36-241268
- 36-241270
- Exp. 7/19/2023
- 36-241443
- Exp. 7/20/2023
- 36-242436
- 36-242439
- Exp. 7/25/2023
- 36-243517
- 36-243738
- Exp. 7/30/2023
- 36-245656
- Exp. 8/2/2023
- 36-246154
- 36-246169
- 36-246672
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 95 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 95 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24